Nectar Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Nectar Lifesciences Ltd · Financial Result · 14 Nov 2026, 5:28 pm
Nectar Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1.1 (-98.5% YoY | -97.5% QoQ) ■ EBITDA: -668 (Profit to Loss YoY | +75.5% QoQ) ■ EBITDA Margin (%): -60,694 (Profit to Loss YoY | -5452492 bps QoQ) ■ PAT: 272 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.14 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Nectar Lifesciences Ltd
- Nectar Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- NECTAR LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
- Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial results .... · 14 Nov 2026
- Please find attached herewith copy of minutes of 31st AGM of the Company. · 05 Oct 2026
- Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015 · 03 Oct 2026
- Please find attached herewith Revised Proceedings of 31st AGM · 19 Sept 2026
- Please find attached herewith outcome of Annual General Meeting held on September 18, 2026 with a copy Scrutinizer report and voting results. · 18 Sept 2026
